David I. Watkins

George Washington University — United States

Immunology and Microbiology · Life Sciences

65h-index15.1kcitations260works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(122), Immune Cell Function and Interaction(114), T-cell and B-cell Immunology(84), Immunotherapy and Immune Responses(45), Mosquito-borne diseases and control(29)

Publications260 total

Acute-phase innate immune responses in SIVmac239-infected Mamu-B*08+ Indian rhesus macaques may contribute to the establishment of elite control
Frontiers in Immunology·2024· 2 citedOpen Access
DIP-RL: Demonstration-Inferred Preference Learning in Minecraft
arXiv (Cornell University)·2023· 1 citedOpen Access
Identity and the Demand for Inclusion: The Critique of Methodological Nationalism and the Political Theory of Immigration
2023· 1 cited
Supplementary Figure 4 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Data from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Data from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
Supplementary Figure 6 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Figure 3 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Tables from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
Supplementary Figure Legends, Tables 1 - 3 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Figure 2 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Figure 1 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Data from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
Supplementary Figure 1 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Data from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
Supplementary Figure 5 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Figure 6 from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Data from High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
2023Open Access
Supplementary Table S4 from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
Supplementary Tables from Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
2023Open Access
page 1 of 13Next →

Frequent Co-authors

David H. O’Connor(15), Nancy A. Wilson(14), Dennis R. Burton(11), Todd M. Allen(9), Alessandro Sette(9), David B. Allison(8), Eva G. Rakasz(8), Bianca R. Mothé(7), Austin L. Hughes(7), Ronald C. Desrosiers(7), Thomas C. Friedrich(7), Adrian B. McDermott(7), John D. Altman(6), Steven M. Wolinsky(6), Shari M. Piaskowski(6), Levi Yant(6), John Sidney(6), Peicheng Jing(5), Thorsten U. Vogel(5), Diogo M. Magnani(5)